Ozempic Category Killer? MariTide Requires Less Frequent Doses Than Other GLP-1s
Just in time for the potential weight gains of Thanksgiving weekend, pharma’s Amgen on Tuesday unveiled impressive results for its budding obesity drug MariTide: for participants, up to 20% average weight loss after 52 weeks of trial, with an expectation …